Page 9 - Sohini Das

More speed, accuracy: AI a booster shot for hospitals, diagnostic companies

Hospital chains like Apollo and Aster lead the way as AI boosts accuracy, cuts costs, and transforms patient outcomes

Simple Energy develops India's first heavy rare earth-free EV motor

This shields the e2W maker from dependence on elusive Chinese imports of critical minerals

PV production fell 4.1% in August as OEMs cut dispatches to dealers

Passenger vehicle production and dispatches fell in August as demand weakened after GST 2.0, while two- and three-wheeler sales recorded strong growth, led by scooters and SUVs

India's auto-component industry to touch $200 bn by 2030: McKinsey

Domestic autocomp sales are projected to grow 7-8 % per annum until financial year 2030

Auto Inc seeks closer ties with Centre for critical raw materials

It is working on a plan to secure supplies for next two-three quarters

Helped by GST move, PV sales growth may rebound to 7% by FY27: Maruti

Maruti Suzuki sees passenger vehicle growth returning to 7% CAGR by FY27, with small car sales projected to rise 10% as GST cuts, tax relief and lower EMIs boost demand

Auto firms assure all cars made since 2023 can run safely on E20 fuel

Automakers including M&M, Tata Motors and Hyundai confirm vehicles made since 2023 are safe on E20 fuel, countering fears as Gadkari calls social media criticism politically driven

Auto dealers shower discounts before GST shift with 600k vehicles in stock

Overall amount paid by dealers in compensation cess is estimated to be in excess of Rs 4000 crore

Despite China's assurance, rare-earth magnet supply eludes automakers

Despite China's assurance, Indian automakers are yet to get rare earth supplies, deepening EV and auto component uncertainty

Auto Inc's big data move: Vahan likely to take the wheel by January

OEMs already favour retail market share based data to forecast production and dispatches

Maruti to Tata Motors: Auto companies start passing on GST cut to buyers

Maruti's Alto could see a price drop by ₹40,000-50,000, while the entry-level Wagon R may see reductions between ₹60,000 and ₹67,000

Citroen to double India market share in 3 months with Basalt X SUV

Citroen eyes stronger India play with Basalt X SUV, aiming to double market share in three months while exports from Thiruvallur are projected to cross 10,000 units in FY26

GST cuts boost auto sector, dealers hope for quick cess resolution

Auto dealers expect a boost in the second half of FY25 following GST cuts on vehicles and parts, which aim to improve affordability

Patients to benefit from GST rate cut, but firms likely to face pressure

GST rationalisation lowers costs for medical consumables and high-end therapies, benefiting patients. However, pharma companies, particularly in biologics, may face margin pressure due to ITC loss

When romance meets the rulebook: How cos deal with workplace relationships

Several Indian companies have similar safeguards in place, though few were forthcoming about their policies when contacted

Luxury car buyers may get 5-8% price benefit: Mercedes-Benz India MD & CEO

Mercedes-Benz India MD & CEO Santosh Iyer says GST rationalisation will boost festive sales, with buyers set to gain 5-8% price benefit

Prices of diagnostic tests unlikely to change much despite GST rate cut

GST reduction on medical devices, diagnostic kits, and reagents is a welcome move, but leading diagnostic players believe test prices will remain largely unaffected due to minimal changes

Health ministry looks to reduce drug development, approval timelines

The Union Health Ministry has proposed amendments to NDCT Rules 2019 to reduce test licence timelines from 90 to 45 days and ease approvals for BA/BE studies

Ethical marketing code: Cost of compliance may rise for drug, device firms

UCPMPD 2024 boosts transparency and ethics, but smaller firms may struggle with higher costs and reporting demands

Tariffs, costs, and shifting strategies: Indian pharma's new playbook

Analysts say Indian pharma firms will increase focus on non-US exports and the domestic market as US tariff threats persist, with firms exploring offshore manufacturing options